Previous close | 21.99 |
Open | 21.99 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 21.99 - 22.21 |
52-week range | 21.99 - 79.15 |
Volume | |
Avg. volume | 345 |
Market cap | 7.247M |
Beta (5Y monthly) | 0.24 |
PE ratio (TTM) | 0.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
DUBLIN, March 05, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.